Annovis Bio, INC DEF 14A proxy statements

Annovis Bio, Inc. has issued its 2026 proxy statement detailing director elections, auditor ratification, and proposed equity plan amendments.

Annovis Bio, Inc. will hold its annual stockholders meeting virtually on June 17, 2025, to elect directors and ratify the selection of Ernst & Young LLP as its independent accounting firm.

Annovis Bio, Inc. has scheduled its 2025 Annual Meeting of Stockholders for June 17, 2025, to be held virtually.

Annovis Bio's CEO, Maria Maccecchini, issued a letter to stockholders addressing concerns and outlining next steps following the Phase II/III Alzheimer's study results.

Annovis Bio, Inc. will hold its annual meeting of stockholders virtually on June 12, 2024, to vote on the election of directors, an amendment to the equity incentive plan, and the ratification of Ernst & Young LLP as the independent accounting firm.

Annovis Bio is holding its 2024 Annual Meeting of Stockholders virtually on June 12, 2024, to vote on director elections, an amendment to the 2019 Equity Incentive Plan, and ratification of Ernst & Young LLP as the independent auditor.